0002001011-24-000017.txt : 20240216
0002001011-24-000017.hdr.sgml : 20240216
20240216201017
ACCESSION NUMBER: 0002001011-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Espinoza Octavio
CENTRAL INDEX KEY: 0001905248
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 24650313
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-02-15
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001905248
Espinoza Octavio
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-02-15
4
F
0
1479
74.65
D
21423
D
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
2024-02-16